...
首页> 外文期刊>Journal of Medicinal Chemistry >Dual Protein Farnesyltransferase-Geranylgeranyltransferase-I inhibitors as Potential Cancer Chemotherapeutic Agents
【24h】

Dual Protein Farnesyltransferase-Geranylgeranyltransferase-I inhibitors as Potential Cancer Chemotherapeutic Agents

机译:双蛋白法呢基转移酶-Geranylgeranyltransferase-I抑制剂作为潜在的癌症化学治疗剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A series of novel diaryl ether lactams have been identified as very potent dual inhibitors of protein farnesyltransferase (FTase) and protein geranylgeranyltransferase I (GGTase-I), enzymes involved in the prenylation of Ras. The structure of the complex formed between one of these compounds and FTase has been determined by X-ray crystallography. These compounds are the first reported to inhibit the prenylation of the important oncogene Ki-Ras4B in vivo. Unfortunately, doses sufficient to achieve this endpoint were rapidly lethal.
机译:一系列新的二芳基醚内酰胺已被确定为非常有效的蛋白法呢基转移酶(FTase)和蛋白geranylgeranyltransferase I(GGTase-I)的双重抑制剂,这些酶涉及Ras的烯丙基化。这些化合物之一与FTase之间形成的配合物的结构已通过X射线晶体学确定。这些化合物是第一个被报道在体内抑制重要癌基因Ki-Ras4B异戊二烯化的化合物。不幸的是,足以达到该终点的剂量迅速致命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号